Insulin Syringes Market Analysis | United States | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Pages: 56
  • Published Date: 11/1/2016
  • Type: MedCore

Although conventional insulin syringes were once a popular method of insulin delivery, patients are transitioning towards new technologies such as insulin pens and pumps. Unit sales will continue to decline over the forecast period in conjunction with the growing penetration rate of insulin pens, as well as the growing penetration rate of insulin pumps among the type 2 insulin-dependent patient population. Mild ASP depreciation will also contribute to erosion in the value of the conventional insulin syringe market.

Insulin syringes are moving from being hypodermic to those with finer points. Syringes are used with 10 mL insulin vials and come in 0.3 mL, 0.5 mL and 1 mL calibrations. In addition, thinner and shorter syringes are becoming more popular in the market, as they cause less discomfort when giving an injection. Needle thickness is indicated by gauge number; the higher the gauge number, the thinner the needle.

Segments Covered in This Market

  • Conventional Insulin Syringe Market
  • Safety Insulin Syringe Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the companies in the U.S. Insulin Syringe market, Becton Dickinson was the leader, followed by Medtronic. Since 1988, BD has developed safety needles and complementary devices to protect users from needlestick injuries and exposure to blood-borne pathogens. It is expected that the company’s large safety device portfolio and its initiatives to combat some of the major concerns of healthcare systems will cause it to grow or at least maintain its strong presence in the U.S. insulin syringe and pen needle markets. Other notable competitors in this segment include Abbott, B. Braun, and Smiths Medical.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled U.S. Market Report Suite for Diabetes Monitoring, Treatment and Drug Delivery – MedSuite

Learn More about these product types

The "US Market Report Suite for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Novo Nordisk
Eli Lilly
Johnson & Johnson
Becton Dickinson
Trividia Health
Nova Biomedical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology